Calls to Action: REPR announced 41% increase in sales for Q1 2015 vs prior year. Appoints COO. Coding as GeoBargain on the radar. Comfortable adding to our position prior to interview. General Highlights: ChinaHybrid YGE announced the official commissioning of […]
REPR engages in the design, manufacture, and marketing of proprietary medical devices primarily for emergency medical applications and ambulatory infusion therapy worldwide. We have been tracking REPR since 2009. Since then shares have traded in a range between $0.10 and […]